nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CREB1—NOTCH2 intracellular domain regulates transcription—GZMB—vitiligo	0.07	0.07	CbGpPWpGaD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—MITF—vitiligo	0.0336	0.0336	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH2—GZMB—vitiligo	0.0328	0.0328	CbGpPWpGaD
Naloxone—OPRD1—Peptide GPCRs—MC1R—vitiligo	0.0231	0.0231	CbGpPWpGaD
Naloxone—TLR4—Primary Focal Segmental Glomerulosclerosis FSGS—CD80—vitiligo	0.0223	0.0223	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—NLRP1—vitiligo	0.0221	0.0221	CbGpPWpGaD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—vitiligo	0.022	0.022	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—MC1R—vitiligo	0.0203	0.0203	CbGpPWpGaD
Naloxone—OPRD1—Peptide GPCRs—CCR6—vitiligo	0.0173	0.0173	CbGpPWpGaD
Naloxone—OPRM1—Peptide GPCRs—MC1R—vitiligo	0.0171	0.0171	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—CD80—vitiligo	0.0168	0.0168	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.0166	0.0166	CbGpPWpGaD
Naloxone—TLR4—Immune System—LRR1—vitiligo	0.0161	0.0161	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—CCR6—vitiligo	0.0152	0.0152	CbGpPWpGaD
Naloxone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.0144	0.0144	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—SH2B3—vitiligo	0.014	0.014	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—CD80—vitiligo	0.0131	0.0131	CbGpPWpGaD
Naloxone—TLR4—Immune System—NLRP1—vitiligo	0.0128	0.0128	CbGpPWpGaD
Naloxone—OPRM1—Peptide GPCRs—CCR6—vitiligo	0.0128	0.0128	CbGpPWpGaD
Naloxone—TLR4—Immune System—HERC2—vitiligo	0.0122	0.0122	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—GZMB—vitiligo	0.012	0.012	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—MC1R—vitiligo	0.0109	0.0109	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—SH2B3—vitiligo	0.0104	0.0104	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—SH2B3—vitiligo	0.00981	0.00981	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CCR6—vitiligo	0.0096	0.0096	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—IFIH1—vitiligo	0.0096	0.0096	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—MC1R—vitiligo	0.00954	0.00954	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—LRR1—vitiligo	0.00925	0.00925	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—CD8A—vitiligo	0.00864	0.00864	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.00852	0.00852	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—CCR6—vitiligo	0.00813	0.00813	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—MC1R—vitiligo	0.00806	0.00806	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NLRP1—vitiligo	0.0077	0.0077	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.00747	0.00747	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.0073	0.0073	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CCR6—vitiligo	0.00713	0.00713	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HERC2—vitiligo	0.00701	0.00701	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.007	0.007	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—CCR6—vitiligo	0.00686	0.00686	CbGpPWpGaD
Naloxone—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.00676	0.00676	CbGpPWpGaD
Naloxone—CREB1—Constitutive PI3K/AKT Signaling in Cancer—CD80—vitiligo	0.00674	0.00674	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.0064	0.0064	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—CD8A—vitiligo	0.00638	0.00638	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.00636	0.00636	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.00631	0.00631	CbGpPWpGaD
Naloxone—CREB1—PI-3K cascade—CD80—vitiligo	0.00607	0.00607	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CCR6—vitiligo	0.00602	0.00602	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CCR6—vitiligo	0.00601	0.00601	CbGpPWpGaD
Naloxone—CREB1—PI3K/AKT activation—CD80—vitiligo	0.00592	0.00592	CbGpPWpGaD
Naloxone—CREB1—GAB1 signalosome—CD80—vitiligo	0.00588	0.00588	CbGpPWpGaD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—vitiligo	0.00574	0.00574	CbGpPWpGaD
Naloxone—CREB1—Immune System—LRR1—vitiligo	0.00561	0.00561	CbGpPWpGaD
Naloxone—TLR4—Immune System—IFIH1—vitiligo	0.00559	0.00559	CbGpPWpGaD
Naloxone—TLR4—Immune System—CCR6—vitiligo	0.00559	0.00559	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.00558	0.00558	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—MC1R—vitiligo	0.00556	0.00556	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00545	0.00545	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.00541	0.00541	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—GZMB—vitiligo	0.00537	0.00537	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CCR6—vitiligo	0.00508	0.00508	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CASP7—vitiligo	0.00492	0.00492	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—MC1R—vitiligo	0.00487	0.00487	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00478	0.00478	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.00471	0.00471	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—CAT—vitiligo	0.00469	0.00469	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00459	0.00459	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—CD80—vitiligo	0.00454	0.00454	CbGpPWpGaD
Naloxone—CREB1—Immune System—NLRP1—vitiligo	0.00449	0.00449	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—CD80—vitiligo	0.00434	0.00434	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CTLA4—vitiligo	0.00432	0.00432	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD44—vitiligo	0.0043	0.0043	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—CD80—vitiligo	0.00427	0.00427	CbGpPWpGaD
Naloxone—CREB1—Immune System—HERC2—vitiligo	0.00425	0.00425	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTLA4—vitiligo	0.00424	0.00424	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CD80—vitiligo	0.00421	0.00421	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCR6—vitiligo	0.00415	0.00415	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—MC1R—vitiligo	0.00412	0.00412	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—CD80—vitiligo	0.00408	0.00408	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—CD80—vitiligo	0.00406	0.00406	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—CD80—vitiligo	0.00404	0.00404	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00404	0.00404	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—CD80—vitiligo	0.00402	0.00402	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—CD80—vitiligo	0.00396	0.00396	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—CD80—vitiligo	0.00378	0.00378	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—CD80—vitiligo	0.00378	0.00378	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	0.00378	0.00378	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—CD80—vitiligo	0.00375	0.00375	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—CAT—vitiligo	0.00372	0.00372	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—CD80—vitiligo	0.00372	0.00372	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—CD80—vitiligo	0.0037	0.0037	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CCR6—vitiligo	0.00364	0.00364	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—CD80—vitiligo	0.0035	0.0035	CbGpPWpGaD
Naloxone—CYP3A4—Tryptophan metabolism—CAT—vitiligo	0.00338	0.00338	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CCR6—vitiligo	0.00335	0.00335	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IFIH1—vitiligo	0.00335	0.00335	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.00335	0.00335	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD8A—vitiligo	0.00326	0.00326	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—GSTT1—vitiligo	0.00325	0.00325	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—MC1R—vitiligo	0.00314	0.00314	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCR6—vitiligo	0.00308	0.00308	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL2RA—vitiligo	0.00299	0.00299	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL2RA—vitiligo	0.00294	0.00294	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—MC1R—vitiligo	0.00286	0.00286	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—MC1R—vitiligo	0.00285	0.00285	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—CD80—vitiligo	0.0028	0.0028	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—MC1R—vitiligo	0.00275	0.00275	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—CD80—vitiligo	0.00258	0.00258	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—DDX6—vitiligo	0.00253	0.00253	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—MC1R—vitiligo	0.0025	0.0025	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CD80—vitiligo	0.0025	0.0025	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD80—vitiligo	0.00245	0.00245	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTLA4—vitiligo	0.00244	0.00244	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00243	0.00243	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CCR6—vitiligo	0.00235	0.00235	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—MC1R—vitiligo	0.00233	0.00233	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CCR6—vitiligo	0.00214	0.00214	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCR6—vitiligo	0.00213	0.00213	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—MC1R—vitiligo	0.00211	0.00211	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—GSTM1—vitiligo	0.00207	0.00207	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CCR6—vitiligo	0.00206	0.00206	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—GSTM1—vitiligo	0.00204	0.00204	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFIH1—vitiligo	0.00195	0.00195	CbGpPWpGaD
Naloxone—CREB1—Immune System—CCR6—vitiligo	0.00195	0.00195	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD8A—vitiligo	0.00188	0.00188	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCR6—vitiligo	0.00187	0.00187	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GSTT1—vitiligo	0.00174	0.00174	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CCR6—vitiligo	0.00174	0.00174	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MC1R—vitiligo	0.00169	0.00169	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MC1R—vitiligo	0.00168	0.00168	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCR6—vitiligo	0.00158	0.00158	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD44—vitiligo	0.0015	0.0015	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.0015	0.0015	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTLA4—vitiligo	0.00148	0.00148	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MC1R—vitiligo	0.00148	0.00148	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD80—vitiligo	0.00147	0.00147	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD80—vitiligo	0.00141	0.00141	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SH2B3—vitiligo	0.0014	0.0014	CbGpPWpGaD
Naloxone—CREB1—Disease—CD44—vitiligo	0.00139	0.00139	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCR6—vitiligo	0.00126	0.00126	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCR6—vitiligo	0.00126	0.00126	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MC1R—vitiligo	0.00125	0.00125	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL2RA—vitiligo	0.00123	0.00123	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SH2B3—vitiligo	0.0012	0.0012	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SH2B3—vitiligo	0.00119	0.00119	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GZMB—vitiligo	0.00119	0.00119	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GZMB—vitiligo	0.00119	0.00119	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD8A—vitiligo	0.00114	0.00114	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CD44—vitiligo	0.00113	0.00113	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GSTT1—vitiligo	0.00113	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL2RA—vitiligo	0.00112	0.00112	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL2RA—vitiligo	0.00112	0.00112	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GSTM1—vitiligo	0.00111	0.00111	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MC1R—vitiligo	0.00111	0.00111	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR6—vitiligo	0.0011	0.0011	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	0.0011	0.0011	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL2RA—vitiligo	0.00108	0.00108	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SH2B3—vitiligo	0.00105	0.00105	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GZMB—vitiligo	0.00104	0.00104	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2RA—vitiligo	0.00103	0.00103	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2RA—vitiligo	0.000981	0.000981	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CD44—vitiligo	0.00094	0.00094	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR6—vitiligo	0.000932	0.000932	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2RA—vitiligo	0.000913	0.000913	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SH2B3—vitiligo	0.000884	0.000884	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GZMB—vitiligo	0.000879	0.000879	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD80—vitiligo	0.000856	0.000856	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2RA—vitiligo	0.000829	0.000829	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR6—vitiligo	0.000827	0.000827	CbGpPWpGaD
Naloxone—CREB1—Disease—CD80—vitiligo	0.00079	0.00079	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SH2B3—vitiligo	0.000784	0.000784	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GZMB—vitiligo	0.000779	0.000779	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2RA—vitiligo	0.000774	0.000774	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CAT—vitiligo	0.000763	0.000763	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GSTM1—vitiligo	0.00072	0.00072	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2RA—vitiligo	0.000663	0.000663	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2RA—vitiligo	0.000661	0.000661	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2RA—vitiligo	0.00058	0.00058	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTT1—vitiligo	0.000556	0.000556	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CD80—vitiligo	0.000553	0.000553	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTT1—vitiligo	0.000552	0.000552	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CD80—vitiligo	0.000552	0.000552	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2RA—vitiligo	0.00049	0.00049	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTT1—vitiligo	0.000484	0.000484	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CD80—vitiligo	0.000484	0.000484	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CD44—vitiligo	0.000462	0.000462	CbGpPWpGaD
Naloxone—ALB—Metabolism—CD44—vitiligo	0.000459	0.000459	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2RA—vitiligo	0.000434	0.000434	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CD80—vitiligo	0.000409	0.000409	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CD44—vitiligo	0.000402	0.000402	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAT—vitiligo	0.000375	0.000375	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAT—vitiligo	0.000373	0.000373	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CD80—vitiligo	0.000362	0.000362	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTM1—vitiligo	0.000354	0.000354	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTM1—vitiligo	0.000352	0.000352	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAT—vitiligo	0.000326	0.000326	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTM1—vitiligo	0.000308	0.000308	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTT1—vitiligo	0.000298	0.000298	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CD44—vitiligo	0.000248	0.000248	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAT—vitiligo	0.000201	0.000201	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTM1—vitiligo	0.00019	0.00019	CbGpPWpGaD
